Cite Filings / DYN / 0000950170-25-020477

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Dyne Therapeutics, Inc. Filed 2025-02-14 Acc 0000950170-25-020477

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-18 144 Sale of Securities
2025-02-18 144 Sale of Securities
2025-02-18 4 SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…